Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_assertion type Assertion NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_head.
- NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_assertion wasGeneratedBy ECO_0000203 NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_provenance.
- NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_assertion wasDerivedFrom befree-2016 NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_provenance.
- NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_assertion SIO_000772 24878056 NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_provenance.
- NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_assertion evidence source_evidence_literature NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_provenance.
- NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_assertion description "[Teprotumumab (RV 001, R1507) is a human monoclonal anti-IGF-1R blocking antibody currently undergoing a phase 2 clinical trial in patients with active TAO.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1186871.RARqUMq1Dt9ulbdyQd6YsWkGOv7ODw_QW-p6ZtynGk_78130_provenance.